Psychiatric Genomics Consortium associated_with schizophrenia
Evidence from:
primary |
all sources
Evidence (7 sources)
Associations Between Cannabis Use, Polygenic Liability for Schizophrenia, and Cannabis-related Experiences in a Sample of Cannabis Users.
(2023)
PMID:36545904
primary
summary statistics from the most recent Psychiatric Genomics Consortium GWAS of schizophrenia...
confidence: 0.94
Schizophrenia Working Group of the Psychiatric Genomics Consortium ... identified ... associated variants ... for schizophrenia
confidence: 0.94
Recent genetic findings in schizophrenia and their therapeutic relevance.
(2015)
PMID:25315827
cited
Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014 ... identified genome‑wide significant loci for schizophrenia
confidence: 0.90
Recent genetic findings in schizophrenia and their therapeutic relevance.
(2015)
PMID:25315827
cited
In a study ... by the Psychiatric Genetics Consortium (PGC) ... 22 loci ... genome-wide significant for association to schizophrenia.
confidence: 0.90
Heritability and molecular-genetic basis of resting EEG activity: a genome-wide association study.
(2014)
PMID:25387704
cited
genes associated with one or more endophenotypes for schizophrenia by the Consortium on the Genetics of Schizophrenia
confidence: 0.92
Genomewide association studies: history, rationale, and prospects for psychiatric disorders.
(2009)
PMID:19339359
cited
organized the Psychiatric GWAS Consortium which includes ... GWAS studies to date for SCZ ...
confidence: 0.95
scientists ... having GWAS datasets on schizophrenia ... (Psychiatric GWAS Consortium Steering Committee 2009)
confidence: 0.96